These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 22429105

  • 21. Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS).
    Vecchierini MF, Kilic-Huck U, Quera-Salva MA, Members of the MEL consensus group of the SFRMS.
    Rev Neurol (Paris); 2021 Mar; 177(3):245-259. PubMed ID: 32921425
    [Abstract] [Full Text] [Related]

  • 22. The use of prolonged-release melatonin in circadian medicine: a systematic review.
    Del Casale A, Arena JF, Giannetti F, Minervino A, Biggio G, Girardi P.
    Minerva Med; 2024 Apr; 115(2):125-142. PubMed ID: 38713204
    [Abstract] [Full Text] [Related]

  • 23. Effect of melatonin-rich night-time milk on sleep and activity in elderly institutionalized subjects.
    Valtonen M, Niskanen L, Kangas AP, Koskinen T.
    Nord J Psychiatry; 2005 Apr; 59(3):217-21. PubMed ID: 16195124
    [Abstract] [Full Text] [Related]

  • 24. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.
    Rajaratnam SM, Polymeropoulos MH, Fisher DM, Roth T, Scott C, Birznieks G, Klerman EB.
    Lancet; 2009 Feb 07; 373(9662):482-91. PubMed ID: 19054552
    [Abstract] [Full Text] [Related]

  • 25. Searching for new options for treating insomnia: are melatonin and ramelteon beneficial?
    Bellon A.
    J Psychiatr Pract; 2006 Jul 07; 12(4):229-43. PubMed ID: 16883148
    [Abstract] [Full Text] [Related]

  • 26. Melatonin in schizophrenic outpatients with insomnia: a double-blind, placebo-controlled study.
    Suresh Kumar PN, Andrade C, Bhakta SG, Singh NM.
    J Clin Psychiatry; 2007 Feb 07; 68(2):237-41. PubMed ID: 17335321
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countries.
    Clay E, Falissard B, Moore N, Toumi M.
    Eur J Clin Pharmacol; 2013 Apr 07; 69(4):1-10. PubMed ID: 23114457
    [Abstract] [Full Text] [Related]

  • 29. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia.
    Van der Heijden KB, Smits MG, Van Someren EJ, Ridderinkhof KR, Gunning WB.
    J Am Acad Child Adolesc Psychiatry; 2007 Feb 07; 46(2):233-41. PubMed ID: 17242627
    [Abstract] [Full Text] [Related]

  • 30. Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults.
    Tuft C, Matar E, Menczel Schrire Z, Grunstein RR, Yee BJ, Hoyos CM.
    Clin Interv Aging; 2023 Feb 07; 18():49-59. PubMed ID: 36660543
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Current Phase II investigational therapies for insomnia.
    Zisapel N.
    Expert Opin Investig Drugs; 2015 Mar 07; 24(3):401-11. PubMed ID: 25423562
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Pediatric prolonged-release melatonin for insomnia in children and adolescents with autism spectrum disorders.
    Schroder CM, Banaschewski T, Fuentes J, Hill CM, Hvolby A, Posserud MB, Bruni O.
    Expert Opin Pharmacother; 2021 Dec 07; 22(18):2445-2454. PubMed ID: 34314281
    [Abstract] [Full Text] [Related]

  • 36. Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial.
    Cortesi F, Giannotti F, Sebastiani T, Panunzi S, Valente D.
    J Sleep Res; 2012 Dec 07; 21(6):700-9. PubMed ID: 22616853
    [Abstract] [Full Text] [Related]

  • 37. Management of chronic insomnia in elderly persons.
    Bain KT.
    Am J Geriatr Pharmacother; 2006 Jun 07; 4(2):168-92. PubMed ID: 16860264
    [Abstract] [Full Text] [Related]

  • 38. Melatonin agonists and insomnia.
    Ferguson SA, Rajaratnam SM, Dawson D.
    Expert Rev Neurother; 2010 Feb 07; 10(2):305-18. PubMed ID: 20136385
    [Abstract] [Full Text] [Related]

  • 39. Dissolution of Intact, Divided and Crushed Circadin Tablets: Prolonged vs. Immediate Release of Melatonin.
    Chua HM, Hauet Richer N, Swedrowska M, Ingham S, Tomlin S, Forbes B.
    Pharmaceutics; 2016 Jan 07; 8(1):. PubMed ID: 26751472
    [Abstract] [Full Text] [Related]

  • 40. Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia.
    Weiss MD, Wasdell MB, Bomben MM, Rea KJ, Freeman RD.
    J Am Acad Child Adolesc Psychiatry; 2006 May 07; 45(5):512-519. PubMed ID: 16670647
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.